Free Trial
NYSEARCA:PPHCRRD

VanEck Vectors Pharmaceutical ETF (PPHCRRD) Price, Holdings, & News

About VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPHCRRD)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
Assets Under Management
$173.85 million
Dividend Yield
N/A
Net Expense Ratio
0.00%
Aggregate Rating
N/A

ETF Overview

VanEck Vectors Pharmaceutical ETF Expenses

TypePPHCRRDNYSEARCA ETFsAll ETFs
Management Fee0.00%0.51%0.52%
Other Expenses0.00%0.58%0.53%
Total Expense0.00%0.73%0.71%
Fee Waiver0.00%-0.67%-0.57%
Net Expense0.00%0.58%0.59%
Receive PPHCRRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Vectors Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter.

PPHCRRD ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com

PPHCRRD ETF - Frequently Asked Questions

Shares of PPHCRRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Fund Details

Issuer
Fund Name
VanEck Vectors Pharmaceutical ETF
Tax Classification
Current Symbol
NYSEARCA:PPHCRRD
Inception Date
1/1/2100
Fund Manager
N/A
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Benchmark
N/A
Category
Focus
Development Level
Region
Number of Holdings
0

Fund Statistics

Assets Under Management
$173.85 million
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NYSEARCA:PPHCRRD) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners